ICER's analysis of biologics used to treat asthma falls short of adequately addressing factors related to patients' health and quality of life, particularly those with severe, uncontrolled asthma, according to this JMCP article by the Asthma and Allergy Foundation of America's CEO.
Partnership Forum: AMCP defined the ideal state for PROs , their importance and systems needed in a previous forum. Here AMCP brought together thought leaders to discuss and identify tactics to achieve the “ideal state.”
Partnership Forum: Industry leaders convened on October 19, 2017 to discuss this important issue. They found broad consensus on the importance of patient reported outcomes (PRO) in defining value.
Partnership Forum: On December 2, 2014, AMCP brought together 60 health care executives from across the nation for a full day of dialogue on critical issues facing the health care system.